Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer - PharmaTimes Ovarian cancer is the fifth leading cause of deaths from cancer in women

#oncology #womenshealth #CorceptTherapeutics #relacorilant #ovariancancer #cancerinwomen #cortisolmodulatingmedications #platinumresistantovariancancer #ROSELLAtrial #gynaecologicalcancerresearch #glucocorticoidreceptor #cortisolmodulatingtreatments
zurl.co/JWBM3